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Background: This study’s primary aim was to examine age-specific associations between GABRA2, rule breaking,
problematic alcohol use, and substance abuse symptomatology. The secondary aim was to examine the extent to
which rule breaking mediates the GABRA2-substance abuse relationship. Methods: A sample (n = 518) of primarily
male (70.9%) and White (88.8%) adolescents from the Michigan Longitudinal Study was assessed from ages 11–18.
Age-specific effects of GABRA2 on rule breaking, problematic alcohol use, and substance abuse symptomatology
were examined using nested path models. The role of rule breaking as a mediator in the association between GABRA2
and substance abuse outcomes was tested using prospective cross-lagged path models. Results: GABRA2 is
significantly (p < 0.05) associated with rule breaking in mid- to late-adolescence, but not substance abuse
symptomatology across adolescence. GABRA2 effects on problematic alcohol use and substance abuse symptom-
atology operate largely (45.3% and 71.1%, respectively, p < 0.05) via rule breaking in midadolescence. Conclusions:
GABRA2 represents an early risk factor for an externalizing pathway to the development of problematic alcohol and
drug use. Keywords: GABRA2, rule breaking, substance abuse, adolescence, mediation.
Introduction
GABRA2 is a gene encoding the a2 subunit of the
c-aminobutyric acid A receptor (GABAA). Research
identifies allelic variations in GABRA2 as being
associated with alcohol and drug use disorders in
adulthood (e.g. Agrawal et al., 2006; Bauer et al.,
2007; Edenberg et al., 2004; Enoch, Schwartz,
Albaugh, Virkkunen, & Goldman, 2006). A critical
next step is to understand mechanistic pathways in
the development of these endpoints. Integral to this
issue is understanding the mechanisms associated
with susceptibility genes and how risk changes
across age. GABRA2 studies are largely cross-sectional
and focused on adult samples, without reflecting
upon mechanisms of risk (e.g. Agrawal et al., 2006;
Edenberg et al., 2004). Studies examining adoles-
cents have not demonstrated consistent effects of
GABRA2 on alcohol and drug use and abuse (Dick
et al., 2006; Matthews, Hoffman, Zezza, Stiffler, &
Hill, 2007; Sakai et al., 2010). By taking a develop-
mental approach, this paper examines age-specific
relations between GABRA2 and three distinct risk
behaviors (rule breaking, problematic alcohol use,
substance abuse symptomatology) prospectively
across adolescence, and the role of rule breaking
as a mediator in the GABRA2-substance abuse
relationship.
Variants in GABRA2 have been found to be
associated with adult alcohol dependence (e.g. Bauer
et al., 2007; Edenberg et al., 2004; Enoch et al.,
2006), and extended to drug and nicotine
dependence (Agrawal et al., 2006; Cui, Seneviratne,
Gu, & Li, 2012). Yet, efforts to replicate findings
among younger samples are equivocal (Dick et al.,
2006; Matthews et al., 2007; Sakai et al., 2010).
This may be due to the relative effect of genetic
influences compared to environmental influences
during this age. For example, genes may be less
relevant to substance use initiation compared to
social contexts such as peers during early adoles-
cence, whereas the extent of genetic influences tends
to have a stronger impact on substance use disor-
ders in adulthood (Maes et al., 1999). One study
demonstrated that at age 14 genes accounted for
18% of the variance in drinking, compared to nearly
50% at age 18 (Rose, Dick, Viken, Pulkkinen, &
Kaprio, 2001). This underscores the importance of
prospectively examining developmental differences
in the impact of candidate genes on problem behaviors
associated with alcohol and drug dependence risk.
Cascade models posit that there is a sequential
progression from delinquency in childhood, to later
riskier and more problematic behaviors, such as
illicit drug use (Dodge et al., 2009). Across childhood
and adolescence, delinquency is characterized as
rule breaking. During this interval, it reflects nor-
mative transgressions to authority figures (e.g. lying,
stealing). Research generally finds higher levels of
rule breaking behaviors among males compared to
females (Lahey et al., 2006). Rule breaking begins
during early childhood and declines in adulthood
(Shaw, Hyde, & Brennan, 2012), while alcohol use
tends to increase throughout adolescence, peaking
in early adulthood (Kim-Cohen et al., 2003).
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problematic alcohol and drug use in childhood as a
predictor of rule breaking in adolescence (Windle,
2000). Accordingly, this suggests that rather than
focusing on alcohol and drug dependence, there may
be utility in examining risk behaviors preceding use
in adolescence. Yet, rule breaking is largely over-
looked in genetics research. Using a prospective
design, a primary aim of this study was to examine
age-specific effects of GABRA2 on rule breaking and
substance abuse outcomes.
Exploring genetic pathways to substance abuse
may be fruitful since substance abuse often develops
gradually and is typically predicted by risk-related
behaviors (Dick et al., 2006). One study demon-
strated that impulsivity partially mediated the asso-
ciation between GABRA2 and lifetime alcohol
problems in adulthood (Villafuerte, Strumba, Stol-
tenberg, Zucker, & Burmeister, 2013). There is
strong evidence that behavior problems, such as
rule breaking, are associated with impulsivity (Burt
& Donnellan, 2008). GABRA2 is also associated with
conduct disorder (Dick et al., 2006) reflecting impul-
sivity and rule breaking behavior; these symptoms in
turn, predict rates of later substance dependence
(Swendsen et al., 2010). These findings suggest that
behaviors associated with impulsivity such as rule
breaking may be adolescent manifestations of
GABRA2 effects, which may impact the emergence
of problematic substance use. Therefore, our sec-
ondary aim was to examine rule breaking as a
mediator between GABRA2 and problematic alcohol
use and substance abuse symptomatology using a
cross-lagged mediational path model. We are una-
ware of studies investigating rule breaking pathways
from GABRA2 to substance abuse. It was hypothe-
sized that: (a) those carrying the minor G allele would
have higher levels of rule breaking compared to those
with the nonrisk allele, (b) GABRA2 would have weak
direct effects on problematic alcohol use and sub-
stance abuse symptomatology, (c) rule breaking
would mediate the effects of GABRA2 on problematic
alcohol use and substance abuse symptomatology,
and (d) problematic alcohol use and substance
abuse symptomatology would not predict rule
breaking.
Methods
Sample
The sample consisted of adolescents from the Michigan Longi-
tudinal Study (MLS), an ongoing, prospective, multiwave study
(Zucker, Ellis, Fitzgerald, Bingham, & Sander, 1996). The MLS
follows a community sample of high-risk families comprised of
men convicted of drunk driving who met criteria for an alcohol
use disorder (AUD) diagnosis, their son, and their son’s
biological mother. A control sample of low-risk families from
the same neighborhoods without a substance abuse history
was also recruited. Community-identified AUD-diagnosed men
and their families were recruited as an intermediate-risk group.
Full biological siblings were also included. See Zucker et al.
(1996) for a full description of the sample.
Procedure
Parents and children completed assessments following initial
recruitment (Wave 1, ages 3–5) with subsequent assessments
occurring every 3 years (e.g. Wave 2, ages 6–8). Children were
also assessed annually beginning when the child turned 11.
For this study, only self-report measures were examined given
that adolescents report more problem behaviors compared to
collaterals, and the consensus view is that nonreporting is
more of a constraint on validity than manufactured reporting
(Moffitt, Caspi, Rutter, & Silva, 2001). Families were asked to
provide blood or saliva for genotyping. Written informed
consent and assent was obtained from the parents and
adolescents. The Institutional Review Board at the University
of Michigan approved the study.
This sample included 518 children from 304 families.
Approximately one-third (29.9%) of children came from a
single-child family, 186 children (35.9%) had another sibling
participate, 144 (27.8%) had two siblings participate, and 33
(6.4%) had three or four siblings participate in the study.
Participants came from the following alcohol risk categories:
low (37.4%), intermediate (26.2%), and high (36.4%). Due to
recruitment strategies (females and non-White families
included after the initial wave), the sample was predominantly
male (70.9%) and White (88.8%). This is important, as delin-
quency and substance use rates tend to be higher among
males. Participants included in analyses did not differ signif-
icantly from those without available genetic or annual data
(n = 135) on sex, race, rule breaking, problematic alcohol use,
or substance abuse symptomatology at the larger wave-levels
(Waves 4 and 5). Accordingly, missing data likely had minimal
impact on the results. Given that we were interested in
age-related effects, rather than using wave-level data (3-year
span), we calculated values reflecting the maximum value of
problem behavior specific to a 2-year span (e.g. 11–12 years of
age) to balance the availability of longitudinal data with age
specificity.
Measures
Rule breaking. Rule breaking was assessed using the
delinquency subscale of the Youth Self Report (YSR; Achen-
bach, 1991). Items are rated on a 3-point Likert scale (0 = not
true to 2 = very true or often true). Sample items included: I
destroy things belonging to others, I set fires, and I steal from
places other than home. The YSR has been used extensively
and had good internal consistency across the larger wave-level
assessments (Cronbach’s a = 0.88 and 0.87 at Wave 4 and 5,
respectively).
Substance use. To assess substance use outcomes more
germane to adolescence, rather than including a binary
measure of dependence, we examined multiple markers of risk
using the Drinking and Drug History form (Zucker, Fitzgerald,
& Noll, 1990). Dimensional outcomes increase reliability and
power (Kraemer, Noda, & O’Hara, 2004). Problematic alcohol
use was assessed with an item reflecting past year maximum
alcoholic beverages consumed in 24 hr. Past year substance
abuse symptomatology was assessed with the stem, Have you
ever had any of the following things happen because of your
[alcohol] [drug] use? Participants rated problems related to
alcohol use (37-items) and a variety of illicit drugs (22-items)
such as marijuana, cocaine, and hallucinogens. Sample items
included: being absent from school, and experiencing physical
or medical problems . . . because of your alcohol (your drug) use.
The internal consistency for problems related to alcohol use
and illicit drugs was good (Cronbach’s a = 0.99 across
Waves 4 and 5). The combined number of endorsed
drinking- and endorsed drug-related problems was
summed to create a substance abuse symptomatol-
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ogy composite, which also had good internal consis-
tency (Cronbach’s a = 0.98 across Waves 4 and 5).
This questionnaire has been used extensively in a
variety of research and clinical settings (e.g. Buu
et al., 2012; Nigg et al., 2006).
Genotyping. Genetic variation in GABRA2 is distinguished
by numerous single nucleotide polymorphisms (SNPs) that are
in linkage disequilibrium (LD), resulting in two common forms
of the GABRA2 gene ‘Ying-Yan’ haplotypes. This means that it
largely does not matter which SNP is analyzed as any will tag
the haplotypes. For this study, three SNPs were selected:
rs279826, rs279827, and rs279858. All SNPs were in strong
LD (>0.77) and in a region previously implicated in impulsivity,
alcohol, and drug dependence (e.g. Edenberg et al., 2004;
Enoch et al., 2006). SNPs rs279826 (intron 4) and rs279858
(exon 5, K132K) were genotyped by Taqman (Villafuerte et al.,
2012). SNP rs279827 was included in the Illumina Addiction
biology SNP array designed by Hodgkinson et al. (2008) using
the Illumina GoldenGate platform (Illumina Inc., San Diego,
CA). We included duplicates (78 for the array and 12 for the
Taqman assay) and no discrepancies were observed. LD
between markers was calculated with Haploview (Barrett,
Fry, Maller, & Daly, 2005). Sample demographics by SNP are
presented in Table 1. All SNPs were in Hardy–Weinberg equi-
librium. Findings focus on SNP rs279826 for simplicity and
clarity although results were largely consistent across SNPs.
Approximately, half of the sample carried the heterozygous
genotype (AG, n = 261, 50.39%), while a quarter were homo-
zygous for the major allele (AA, n = 133, 25.68%) and the
minor allele (GG, n = 124, 23.94%). Genotype data were
dichotomized (0 = AA, 1 = G-allele carriers) consistent with
previous studies (e.g. Pierucci-Lagha et al., 2005) and given
that most studies found that the minor (but still common)
haplotype increases risk (Bauer et al., 2007; Edenberg et al.,
2004; Enoch et al., 2006).
Data analysis
A series of nested models were run in Mplus version 7.1
(Muthen & Muthen, 1998-2010) to examine age-specific effects
of GABRA2 on rule breaking, problematic alcohol use, and
substance abuse symptomatology. Freely estimated paths
between GABRA2 predicting problem behaviors at four differ-
ent time points (i.e. age 11–12, 13–14, 15–16, and 17–18) were
estimated first. A nested model was then evaluated to assess if
GABRA2 equally predicts problem behaviors at different ages
by constraining all paths to be equal. The change in chi-square
and the Comparative Fit Index (CFI) between the two models
was assessed. Research using simulated data demonstrates
that a change in CFI greater than 0.01 represents a signif-
icant decrement in model fit (Cheung & Rensvold, 2002). In
cases demonstrating a significant change in chi-square and
CFI, modification indices were examined to identify which
paths should be freed. Once age-specific effects of GABRA2
were identified, two cross-lagged mediation path models
including rule breaking and each substance use outcome at
two time points were tested. Sex (0 = females, 1 = males) and
race1 (0 = non-Whites, 1 = Whites) were included as covari-
ates. CFI, Root Mean Square Error of Approximation
(RMSEA), and Tucker-Lewis Index (TLI) were used to determine
model fit following recommended cutoff values (Hu & Bentler,
1999).
As noted, the sample included siblings from the same
nuclear family. Ignoring nested multilevel data structure can
bias results. Therefore, an intercept only model estimated
family clustering. Results indicated that a significant amount
of variance in outcomes was accounted for by family cluster-
ing. Thus, multilevel models were estimated.
A prospective design establishes temporal precedence
between the mediator and outcome, which is key for testing
mediation (Kraemer, Kiernan, Essex, & Kupfer, 2008). In
Mplus, it is not possible to control for clustering while using
resampling approaches. Therefore, indirect effects when con-
trolling for cluster-effects were compared to bias-corrected
bootstrap confidence intervals. Maximum likelihood estima-
tion with robust standard errors was used to accommodate
non-normality in substance use outcomes. The full informa-
tion maximum likelihood estimation was used to handle
missing values.
Results
Table 2 presents descriptive statistics for study
variables. Rule breaking, problematic alcohol use,
and substance abuse symptomatology significantly
(p < 0.001) increased over time, except for the inter-
val between rule breaking behavior at age 15–16 to
age 17–18. GABRA2 had few significant associations
with other study variables. There was evidence for
stability effects and significant associations between
rule breaking, problematic alcohol use, and sub-
stance abuse symptomatology, except for substance
abuse symptomatology at age 11–12.
Nested model analyses
G-allele carriers had high rates (p < 0.01) of rule
breaking at ages 13–14 and 15–16 compared to
those with the AA genotype. A scaling correction to
better approximate chi-square under non-normality
Table 1 Summary of sample demographics by GABRA2 SNPs
Race n (% within SNP) Sex n (% within SNP)
Minority White Female Male
rs279826 (n = 518)
AA (n = 133, 25.68%) 11 (2.12) 122 (23.55) 47 (9.07) 86 (16.60)
G-allele carriers (n = 385, 74.32%) 47 (9.07) 338 (65.25) 104 (20.08) 281 (54.25)
rs279827 (n = 445)
AA (n = 120, 26.97%) 14 (3.15) 106 (23.82) 40 (8.99) 80 (17.98)
G-allele carriers (n = 325, 73.03%) 33 (7.42) 292 (65.62) 86 (19.33) 239 (53.71)
rs279858 (n = 509)
AA (n = 161, 31.63%) 23 (4.52) 138 (27.11) 58 (11.39) 103 (20.24)
G-allele carriers (n = 348, 68.37%) 30 (5.89) 318 (62.48) 92 (18.07) 256 (50.29)
SNPs, single nucleotide polymorphisms.
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was employed as recommended (Satorra, 2000).
Constraining all paths to be equal resulted in a
significant change in chi-square (v2D = 8.20 (3),
p < 0.05) and CFI (DCFI = 0.02) indicating a dec-
rement in model fit. Modification indices suggested
that rule breaking at age 11–12 should be freely
estimated. After freeing this path, a significant
(p < 0.01) effect from GABRA2 to rule breaking was
observed at ages 13–14, 15–16, and 17–18, but not
for rule breaking at age 11–12 (p = 0.94; see Fig-
ure 1). This indicates that G-allele carriers have
higher rates of rule breaking compared to those with
the AA genotype, this association is not significant in
early adolescence, and it is undifferentiated in mid-
to late-adolescence. GABRA2 did not predict sub-
stance use outcomes across adolescence.
Cross-lagged mediation models
Two separate cross-lagged mediation path models
were tested for each outcome. We tested the youn-
gest age (13–14) of rule breaking that was signifi-
cant in the nested model along with the oldest time
period assessed (age 17–18) in order to examine the
effect of early indicators of risk on more distal
outcomes. The problematic alcohol use model pro-
vided a good fit to the data and accounted for 37.8%
and 18.1% of the variance in rule breaking and
problematic alcohol use at age 17–18, respectively
(see Figure 2). Males and G-allele carriers reported
more rule breaking at age 13–14. As expected, rule
breaking at age 13–14 prospectively predicted prob-
lematic alcohol use at age 17–18 above and beyond
previous rates of use; however, problematic alcohol
use did not predict rule breaking. The indirect effect
from GABRA2 to problematic alcohol use was
significant (estimate = 0.69, p = 0.02; 95% bias-
corrected bootstrap confidence interval (BCBCI) =
0.22–1.37) and 45.3% of the total effect of GABRA2
on problematic alcohol use operated through rule
breaking.
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Figure 1 Nested chi-square model. Path to rule breaking age 11–
12 is freely estimated and the other paths are constrained to be
equal. Values represent standardized path coefficients. Dashed
line represents a nonsignificant path; **p < 0.01
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The substance abuse symptomatology model pro-
vided a good fit to the data and accounted for 34.7%
and 11.7% of the variance in rule breaking and
substance abuse symptomatology at age 17–18,
respectively (see Figure 3). Males and G-allele carri-
ers reported more rule breaking at age 13–14, and
White adolescents reported more substance abuse
symptomatology at age 13–14. As expected, rule
breaking at age 13–14 prospectively predicted sub-
stance abuse symptomatology at age 17–18 above
and beyond prior rates of substance abuse, but
substance abuse symptomatology did not predict
rule breaking. The indirect effect from GABRA2 to
substance abuse symptomatology was significant
(estimate = 0.34, p = 0.03; 95% BCBCI = 0.09–0.76)
and 71.1% of the total effect of GABRA2 on sub-
stance abuse symptomatology operated through rule
breaking.
Discussion
Substance abuse has a complex etiology and consid-
erable individual differences in susceptibility.
Advances in genetics research have identified
GABRA2 as predicting alcohol and drug dependence
in adulthood (e.g. Covault, Gelernter, Hesselbrock,
Nellissery, & Kranzler, 2004; Edenberg et al., 2004;
Enoch et al., 2006); yet, findings aremixed in younger
samples (Dick et al., 2006; Matthews et al., 2007;
Sakai et al., 2010). This may be due to the relative
importance of genetic factors in the etiology of sub-
stance dependence across development (Rhee &
Waldman, 2002). Weak direct effects of GABRA2 on
alcohol and drug dependence in adolescence high-
light the need to understanddevelopmental pathways
topsychopathology. This studyexaminedage-specific
effectsofGABRA2acrossadolescenceononenonspecific
0.33*** 
R2 = 0.38**
0.17** 
0.56*** 
0.34***0.36***
0.13**
0.10*
GABRA2 
Sex 
Race 
Rule breaking 
age 13–14 
Rule breaking 
age 17–18 
Problematic 
alcohol use 
age 13–14 
Problematic 
alcohol use 
age 17–18 
R2 = 0.18**
Figure 2 Cross-lagged model for problematic alcohol use. Model fit: RMSEA = 0.019, CFI = 0.996, TLI = 0.985. Values represent
standardized path coefficients. Dashed lines represent nonsignificant paths (*p < 0.05, **p < 0.01, ***p < 0.001). Bold lines represent a
significant mediated path
0.11*
0.27*** 
R2 = 0.35**
0.57**
*
0.46***0.37***
0.13***
0.07***
GABRA2 
Sex 
Race 
Rule breaking 
age 13–14 
Rule breaking 
age 17–18 
Substance abuse 
symptomatology 
age 13–14 
Substance abuse 
symptomatology 
age 17–18 
R2 = 0.12*
Figure 3 Cross-lagged model for substance abuse symptomatology. Model fit: RMSEA = 0.022, CFI = 0.995, TLI = 0.979. Values represent
standardized path coefficients. Dashed lines represent nonsignificant paths (*p < 0.05, **p < 0.01, ***p < 0.001). Bold lines represent a
significant mediated path
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risk behavior and two substance use-specific behav-
iors in a predominantly White male sample. Rule
breaking as a mediator in the relation between
GABRA2 and problematic alcohol use and substance
abuse symptomatology was also examined. Four
study hypotheses were tested: (a) those carrying the
minor allele would have higher levels of rule breaking,
(b) GABRA2 would have weak direct effects on sub-
stance use outcomes, (c) rule breaking wouldmediate
the effects of GABRA2 on substance use outcomes,
and (d) substance use would not predict rule break-
ing. All hypotheses were supported. Namely, G-allele
carriers reported higher levels of rule breaking in
mid-to late-adolescence, while GABRA2 did not pre-
dict substance use outcomes across adolescence.
Rule breaking in mid adolescence mediated the asso-
ciation betweenGABRA2 on substance use outcomes
in late-adolescence. Lastly, substance use did not
predict rule breaking.
Age-specific effects of GABRA2
GABRA2 had a stronger impact on rule breaking in
mid- to late-adolescence versus early adolescence.
Namely, G-allele carriers endorsed higher rates of
rule breaking compared to those homozygous for the
A-allele. This is consistent with work demonstrating
associations between GABRA2 and problem
behaviors (Dick et al., 2006). Animal research dem-
onstrates that GABRA2 receptors are expressed
primarily in the amygdala and areas activated from
the striatum, such as the substantia nigra (Schwar-
zer et al., 2001), which is associated with individual
differences in impulsivity and reward (Brody, Chen,
& Beach, 2013). It is likely that G-allele carriers are
more impulsive or find rule breaking more reward-
ing. It may be that during earlier developmental
periods GABRA2 has a more pronounced effect on
precursors to behavioral problems such as difficult
temperament (e.g. disinhibition; Edenberg et al.,
2004).
GABRA2 did not predict problematic alcohol use or
substance abuse symptomatology across adoles-
cence. Previous research suggests that genetic
effects on substance use outcomes increase as
individuals age, with some reporting a peak effect
at ages 30–33 (Kendler, Gardner, & Dick, 2011).
Conversely, the effects of genetic risk in adolescence
may be nonspecific and impact more general prob-
lem behaviors (Moffitt et al., 2001). Genetic risk for
problematic alcohol and drug use may become more
relevant in early to midadulthood during typical
onset of abuse and dependence (Kendler et al.,
2011). Effects at these ages can be studied in the
MLS when the sample gets older.
Genetic pathways
Findings demonstrate that the pathway from
GABRA2 to substance abuse operates largely via
rule breaking. G-allele carriers endorsed greater
levels of rule breaking behaviors in midadolescence,
which in turn predicted problematic alcohol and
drug use in late-adolescence. This is consistent with
work indicating that impulsivity partially mediates
the association between GABRA2 and alcohol abuse
in adulthood (Villafuerte et al., 2013). It is likely
that G-allele carriers are less likely to ‘mature out’ of
rule breaking and engage in increasingly risky
behaviors associated with greater rewards such as
alcohol and illicit drug use eventually resulting in
problematic use. Clinically, detection of early risk
factors and pathways to the abuse endpoint pro-
vides information regarding who may be especially
susceptible and benefit the most from prevention
efforts. The externalizing pathway posits a develop-
mental trajectory to substance use disorders that
begins with a genetically driven underlying liability
for behavioral disinhibition, which emerges as dif-
ficult temperament in infancy, followed by rule
breaking behavior, and the eventual onset of prob-
lematic alcohol and drug use in later adolescence
and early adulthood (Zucker, 2006). Findings pro-
vide evidence that carrying the GABRA2 G-allele
may represent this early genetic risk for an exter-
nalizing pathway to the development of alcohol and
drug abuse.
Limitations and future directions
Although this work provides a greater understand-
ing of genetic pathways to substance abuse, several
limitations should be noted. Our study was pre-
dominantly comprised of White males. Rates of
delinquency and substance abuse tend to be higher
among males (Lahey et al., 2006). Accordingly, our
findings may not generalize to mixed-sex or pri-
marily female samples. A future direction is to
examine whether sex moderates this pathway using
moderated mediation models. Rates of problem
behaviors also vary across race and ethnicity (Es-
bensen, 2010). We did not have an adequate
number of racial minorities to test these differ-
ences. This sample was enriched for alcoholism,
limiting generalizability of results. Study variables
were based on youth self-report. Although research
suggests that adolescent-report of behavior prob-
lems is more accurate compared to collaterals
(Moffitt et al., 2001), this may increase share-
d-method variance.
Nevertheless, this work provides evidence for the
utility of a genetically informed developmental per-
spective of GABRA2 effects on substance abuse.
Understanding the role of GABRA2 as a risk factor
for substance use disorders warrants prospective
designs that assess behavior more germane to youth
and more proximal to genes. Future work should
test whether this externalizing pathway predicts
nicotine dependence. Investigating additional medi-
ating mechanisms between GABRA2 and substance
© 2014 The Authors. Journal of Child Psychology and Psychiatry. © 2014 Association for Child and Adolescent Mental Health.
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dependence is another important future direction.
For example, research demonstrates that a positive
subjective effect of alcohol is likely enhanced in
individuals with the GABRA2 variant (Arias et al.,
2014). Other work suggests that GABRA2 impacts
temperamental factors such as disinhibition (Eden-
berg et al., 2004). Given that difficult temperament
typically precedes rule breaking, temperament is
likely to be a mediator of GABRA2 in childhood.
Future work involving reward-processing areas as
potential mediators, such as differential activation
in the striatum and the nucleus acumbens, also
seems warranted given prior work (Sieghart & Sperk,
2002).
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Key points
• GABRA2 variants indirectly predict the development of alcohol and drug dependence in adulthood.
• There is weak support for the role of GABRA2 on alcohol and drug dependence in adolescence.
• GABRA2 may represent an early risk factor for an externalizing pathway to the development of alcohol and
substance use problems.
• Cross-lagged path models support the role of rule breaking as a mediator in the association between GABRA2
and substance abuse outcomes.
• GABRA2 is relevant in younger developmental periods, but its impact on substance abuse outcomes operates
largely via rule breaking behavior.
Note
1. Given a largely White sample, analyses were also
conducted on White participants only. Findings were
comparable and frequency genotypes did not differ
by race (v2 (1) = 1.54, p = 0.21). Accordingly, results
include consideration of the full sample.
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